These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 918481)

  • 1. [Isoniazid acetylation among Brazilian Caucasoids and Negroids with pulmonary tuberculosis].
    Beiguelman B; Ramalho AS; Arena JF; Garlipp CR
    Rev Paul Med; 1977; 89(1-2):12-5. PubMed ID: 918481
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Variability of isoniazid pharmacokinetics].
    Sokolova GB; Ivleva AIa; Ziia AV; Vilenskaia RN
    Farmakol Toksikol; 1982; 45(3):101-4. PubMed ID: 7095118
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.
    Eidus L; Hodgkin MM; Hsu AH; Schaefer O
    Am Rev Respir Dis; 1974 Jul; 110(1):34-42. PubMed ID: 4834616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoniazid acetylation in São Paulo descendants of Japanese].
    Garlipp CR; Ramalho AS; Beiguelman B
    AMB Rev Assoc Med Bras; 1982; 28(7-8):179-81. PubMed ID: 6984947
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of various isoniazid slow releasing matrix preparations for intermittent chemotherapy of tuberculosis.
    Hodgkin MM; Eidus L; Hershfield ES
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):349-65. PubMed ID: 461989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid acetylator phenotypes of Nigerians.
    Afonja AO; Arhavwarien ED; Okotore RO; Femi-Pearse D
    Niger Med J; 1979 Jan; 9(1):86-8. PubMed ID: 463346
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid acetylator phenotyping of Amharas in Ethiopia.
    Russell SL; Russell DW
    Afr J Med Sci; 1973 Jan; 4(1):1-5. PubMed ID: 4695980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modified method for indicating antitubercular agents in the urine in tuberculosis].
    Solov'eva AS; Lukomskaia VM
    Lab Delo; 1980; (12):756-7. PubMed ID: 6163900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of liver function in pulmonary tuberculosis with the aid of ueviridin test and the indicators of urinary excretion of antitubercular agents].
    Savula MM; Tytor IaM; Piatnochka IT
    Sov Med; 1976 Nov; (11):109-12. PubMed ID: 1006371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
    Ellard GA
    Tubercle; 1984 Sep; 65(3):211-27. PubMed ID: 6385429
    [No Abstract]   [Full Text] [Related]  

  • 16. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
    Guerra RL; Conde MB; Efron A; Loredo C; Bastos G; Chaisson RE; Golub JE
    Respir Med; 2010 May; 104(5):754-7. PubMed ID: 20202806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of inactivation of phthivazid in the therapy of tuberculosis in children].
    Aminov NR
    Probl Tuberk; 1965; 43(8):29-33. PubMed ID: 5296614
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
    Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA
    Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
    Powłowska I; Rakowska Z
    Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.